Announce Date | 01/29/2025 |
EPS Normalized Actual | $0.57 (Beat by $0.0099999999999999) |
EPS GAAP Actual | $0.57 (Beat by $0.0099999999999999) |
Revenue Actual | $3.501B |
Revenue Surprise | Beat by $3501M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $0.52429 |
EPS GAAP Estimate | $0.52429 |
Revenue Estimate | $3.608945883B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 2.43 | 16.46 | 2.37241 | 2.49411 | 1 |
Dec 2026 | 1.99261 | 20.07 | 1.36226 | 2.25303 | 5 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.36 | 0.36 | 3.501B | 14.48% | 3501M |
FQ3 2024 (Sep 2024) | 0.22 | 0.22 | 3.391B | 6.43% | 3391M |
FQ2 2024 (Jun 2024) | 0.26 | 0.26 | 3.251B | 0.25% | 3251M |
FQ1 2024 (Mar 2024) | 0.25 | 0.25 | 2.975B | -6.82% | 2975M |
FQ4 2023 (Dec 2023) | -0.05 | -0.05 | 2.994B | -13.76% | 2994M |
FQ3 2023 (Sep 2023) | 0.19 | 0.19 | 3.173B | -9.93% | 3173M |
FQ2 2023 (Jun 2023) | 0.33 | 0.33 | 3.243B | -11.47% | 3243M |
FQ1 2023 (Mar 2023) | 0.23 | 0.23 | 3.178B | 100% | 3178M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
0.52429
Consensus Revenue Estimates
3.608945883B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.77058 | -- | 0.76701 | 0.78005 | 3 |
FQ2 2027 (Jun 2027) | 0.7512 | -- | 0.74772 | 0.76043 | 5 |
FQ1 2027 (Mar 2027) | 0.64667 | -- | 0.64367 | 0.65462 | 3 |
FQ4 2026 (Oct 2026) | 0.59598 | -- | 0.58272 | 0.61136 | 3 |
FQ3 2026 (Jul 2026) | 0.57343 | -- | 0.56067 | 0.58822 | 5 |
FQ2 2026 (Jun 2026) | 0.5506 | -- | 0.53223 | 0.5657 | 5 |
FQ1 2026 (Mar 2026) | 0.51239 | -- | 0.49529 | 0.52644 | 3 |
FQ4 2025 (Oct 2025) | 0.59043 | 39.03 | 0.57729 | 0.60566 | 4 |
FQ3 2025 (Jul 2025) | 0.52921 | 58.43 | 0.51743 | 0.54286 | 6 |
FQ2 2025 (Jun 2025) | 0.52429 | 50.41 | 0.5068 | 0.53867 | 6 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 4.42B | -- | 4.41B | 4.46B | 2 |
FQ2 2027 (Jun 2027) | 4.32B | -- | 4.3B | 4.36B | 2 |
FQ1 2027 (Mar 2027) | 3.87B | -- | 3.86B | 3.91B | 2 |
FQ4 2026 (Oct 2026) | 3.92B | -- | 3.85B | 4B | 4 |
FQ3 2026 (Jul 2026) | 3.78B | -- | 3.72B | 3.86B | 5 |
FQ2 2026 (Jun 2026) | 3.71B | -- | 3.61B | 3.78B | 5 |
FQ1 2026 (Mar 2026) | 3.55B | -- | 3.46B | 3.62B | 6 |
FQ4 2025 (Oct 2025) | 3.83B | 8.59 | 3.76B | 3.91B | 2 |
FQ3 2025 (Jul 2025) | 3.64B | 6.79 | 3.58B | 3.71B | 2 |
FQ2 2025 (Jun 2025) | 3.61B | 9.92 | 3.52B | 3.69B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | 0.36 | 0.36 | 100% | |
FQ3 2024 (Sep 2024) | 0.22 | 0.22 | 100% | |
FQ2 2024 (Jun 2024) | 0.26 | 0.26 | 100% | |
FQ1 2024 (Mar 2024) | 0.25 | 0.25 | 100% | |
FQ4 2023 (Dec 2023) | -0.05 | -0.05 | 100% | |
FQ3 2023 (Sep 2023) | 0.19 | 0.19 | 100% | |
FQ2 2023 (Jun 2023) | 0.33 | 0.33 | 100% | |
FQ1 2023 (Mar 2023) | 0.23 | 0.23 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ4 2024 (Dec 2024) | $0B | $3.5B | $3501M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.39B | $3391M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.25B | $3251M | 100% |
FQ1 2024 (Mar 2024) | $0B | $2.98B | $2975M | 100% |
FQ4 2023 (Dec 2023) | $0B | $2.99B | $2994M | 100% |
FQ3 2023 (Sep 2023) | $0B | $3.17B | $3173M | 100% |
FQ2 2023 (Jun 2023) | $0B | $3.24B | $3243M | 100% |
FQ1 2023 (Mar 2023) | $0B | $3.18B | $3178M | 100% |